Cargando…
Studying epigenetic complexes and their inhibitors with the proteomics toolbox
Some epigenetic modifier proteins have become validated clinical targets. With a few small molecule inhibitors already approved by national health administrations and many more in the pharmaceutical industry pipelines, there is a need for technologies that can promote full comprehension of the molec...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2016
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4950666/ https://www.ncbi.nlm.nih.gov/pubmed/27437033 http://dx.doi.org/10.1186/s13148-016-0244-z |